Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Renato B. Baleeiro, Christian J. Bouwens, Peng Liu, Carmela Di Gioia, Louisa S. Chard Dunmall, Ai Nagano, Rathistevy Gangeswaran, Claude Chelala, Hemant M. Kocher, Nicholas R. Lemoine & Yaohe Wang. (2022) MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (25)
Anne M Macy, Lauren M Herrmann, Anngela C Adams & K Taraszka Hastings. (2023) Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells. Current Opinion in Immunology 83, pages 102330.
Crossref
Crossref
Manuel Ruiz-Pablos. (2022) CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases. Pathogens 11:8, pages 831.
Crossref
Crossref
Christian M. Tegeler, Jonas Scheid, Hans-Georg Rammensee, Helmut R. Salih, Juliane S. Walz, Jonas S. Heitmann & Annika Nelde. (2022) HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients. Cancers 14:9, pages 2260.
Crossref
Crossref
Chiara Prampolini, Giovanni Almadori, Davide Bonvissuto, Marta Barba, Luca Giraldi, Stefania Boccia, Gaetano Paludetti, Jacopo Galli, Ornella Parolini, Stefano Settimi & Gabriella Cadoni. (2021)
Immunohistochemical detection of “ex novo”
HLA‐DR
in tumor cells determines clinical outcome in laryngeal cancer patients
. HLA 98:6, pages 517-524.
Crossref
Crossref
Ilana Berger Fridman, James Kostas, Michal Gregus, Somak Ray, Matthew R. Sullivan, Alexander R. Ivanov, Smadar Cohen & Tania Konry. (2021) High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment. Acta Biomaterialia 132, pages 473-488.
Crossref
Crossref
Stefanie Meyer, Diana Handke, Anja Mueller, Katharina Biehl, Markus Kreuz, Jürgen Bukur, Ulrike Koehl, Maria-Filothei Lazaridou, Mark Berneburg, André Steven, Chiara Massa & Barbara Seliger. (2021) Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma. Cancers 13:15, pages 3907.
Crossref
Crossref
Xuan-Mei Piao, Ho Won Kang, Pildu Jeong, Young Joon Byun, Hee Youn Lee, Kyeong Kim, Sung Phil Seo, Won Tae Kim, Jong-Young Lee, Yun-Sok Ha, Yung Hyun Choi, Sung-Kwon Moon, Seok Joong Yun & Wun-Jae Kim. (2021) A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations 39:4, pages 237.e21-237.e29.
Crossref
Crossref
Farhad Ghasemi, Tanner M. Tessier, Steven F. Gameiro, Allison H. Maciver, Matthew J. Cecchini & Joe S. Mymryk. (2020) High MHC-II expression in Epstein–Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation. Scientific Reports 10:1.
Crossref
Crossref
Rod Balhorn & Monique Cosman Balhorn. (2020) Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers. Oncotarget 11:35, pages 3315-3349.
Crossref
Crossref
Maysaloun Merhi, Afsheen Raza, Varghese Philipose Inchakalody, Kodappully S Siveen, Deepak Kumar, Fairooz Sahir, Sarra Mestiri, Shereena Hydrose, Niloofar Allahverdi, Munir Jalis, Allan Relecom, Lobna Al Zaidan, Mohamed Sir Elkhatim Hamid, Mai Mostafa, Abdul Rehman Zar Gul, Shahab Uddin, Mohammed Al Homsi & Said Dermime. (2020) Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report. Journal for ImmunoTherapy of Cancer 8:2, pages e001278.
Crossref
Crossref
Margaret R. Dunne, James J. Phelan, Adriana J. Michielsen, Aoife A. Maguire, Cara Dunne, Petra Martin, Sinead Noonan, Miriam Tosetto, Robert Geraghty, David Fennelly, Kieran Sheahan, Elizabeth J. Ryan & Jacintha O’Sullivan. (2020) Characterising the prognostic potential of HLA-DR during colorectal cancer development. Cancer Immunology, Immunotherapy 69:8, pages 1577-1588.
Crossref
Crossref
Aikaterini Mastoraki, Dimitrios Schizas, Nikolaos Charalampakis, Leon Naar, Maria Ioannidi, Diamantis Tsilimigras, Maria Sotiropoulou, Dimitrios Moris, Pantelis Vassiliu & Evangelos Felekouras. (2020) Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma. Molecular Diagnosis & Therapy 24:2, pages 175-184.
Crossref
Crossref
Yayi He, Leslie Rozeboom, Christopher J Rivard, Kim Ellison, Rafal Dziadziuszko, Hui Yu, Caicun Zhou & Fred R Hirsch. (2017) MHC class II expression in lung cancer. Lung Cancer 112, pages 75-80.
Crossref
Crossref
Margaret R. Dunne, Adriana J. Michielsen, Katie E. O’Sullivan, Mary Clare Cathcart, Ronan Feighery, Brendan Doyle, Jenny A. Watson, Naoimh J. O’Farrell, Narayanasamy Ravi, Elaine Kay, John V. Reynolds, Elizabeth J. Ryan & Jacintha O’Sullivan. (2017) HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients. Cancer Immunology, Immunotherapy 66:7, pages 841-850.
Crossref
Crossref
Kouji Okada, Shuko Hakata, Jun Terashima, Toshie Gamou, Wataru Habano & Shogo Ozawa. (2016) Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells. Oncology Reports 36:4, pages 1875-1885.
Crossref
Crossref
Fatima Solange Pasini, Bruno Zilberstein, Igor Snitcovsky, Rosimeire Aparecida Roela, Flavia R. Rotea Mangone, Ulysses RibeiroJr.Jr., Suely Nonogaki, Glauber Costa Brito, Giovanna D. Callegari, Ivan Cecconello, Venancio Avancini Ferreira Alves, José Eluf-Neto, Roger Chammas & Miriam Hatsue Honda Federico. (2013) A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma. Journal of Gastroenterology 49:11, pages 1453-1466.
Crossref
Crossref
S Dutta, J J Going, A B C Crumley, Z Mohammed, C Orange, J Edwards, G M Fullarton, P G Horgan & D C McMillan. (2012) The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. British Journal of Cancer 106:4, pages 702-710.
Crossref
Crossref
Andrew B. C. Crumley, James J. Going, Mustafa Hilmy, Sumanta Dutta, Claire Tannahill, Margaret McKernan, Joanne Edwards, Robert C. Stuart & Donald C. McMillan. (2011) Interrelationships between Tumor Proliferative Activity, Leucocyte and Macrophage Infiltration, Systemic Inflammatory Response, and Survival in Patients Selected for Potentially Curative Resection for Gastroesophageal Cancer. Annals of Surgical Oncology 18:9, pages 2604-2612.
Crossref
Crossref
A. DaromI.P. GomatosE. LeandrosE. ChatzigianniC. FotiadisM.M. Konstadoulakis. (2004) HLA-DR Antigen and Bax Protein Expression in Patients with Primary Non-Hodgkin's Gastric Lymphoma. Hybridoma and Hybridomics 23:2, pages 87-92.
Crossref
Crossref
A. Darom, I. P. Gomatos, E. Leandros, E. Xatziyiannis, C. Fotiadis & M. M. Konstadoulakis. (2004) HLA-DR Antigen and Bax Protein Expression in Patients with Primary Non-Hodgkin's Gastric Lymphoma. Hybridoma and Hybridomics 23:2, pages 87-92.
Crossref
Crossref
Maresa Altomonte, Ester Fonsatti, Alberto Visintin & Michele Maio. (2003) Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?. Oncogene 22:42, pages 6564-6569.
Crossref
Crossref
E. Ryschich, F. Autschbach, S. Eisold, E. Klar, M.W. Buchler & J. Schmidt. (2003) Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas. Tissue Antigens 62:1, pages 48-54.
Crossref
Crossref
N J Cope, P McCullagh & P T L Sarsfield. (2006) Tumour responding accessory cells in testicular seminoma: an immunohistochemical study. Histopathology 34:6, pages 510-516.
Crossref
Crossref
Zhong-Xue Hua, Kathryn E Tanaka, Henry D Tazelaar, Jeffrey Myers, Glen S Markowitz & Alain C Borczuk. (1998) Immunoreactivity for LN2 and LN3 distinguishes small cell carcinomas from non-small cell carcinomas in the lung. Human Pathology 29:12, pages 1441-1446.
Crossref
Crossref
Kyogi Ogoshi, Tomoo Tajima, Toshio Mitomi & Kimiyoshi Tsuji. (1996) HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer. Clinical & Experimental Metastasis 14:3, pages 277-281.
Crossref
Crossref